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1. Introduction 
There exists a recessive mutant of the laboratory 
mouse that is characterized byexcessive deposition of 
fat, apparently resulting from increased rates of lipid 
synthesis [1,2]. Conversion of acetate to carbon 
dioxide is diminished while its conversion to lipid is 
significantly enhanced [3], a diversion that occurs 
despite normal or increased levels of mitochondrial 
enzymes concerned with oxide-reductions [4]. These 
animals exhibit a considerable variety of metabolic 
alterations including loss of control of gluconeoge- 
nesis [5], altered levels of blood lipids and sugars 
[6,7] and both hypersecretion a d loss of sensitivity 
to insulin [8]. Although an array of metabolic hanges 
is observed, it is clear that the mutation occurs at a 
single locus [ 1 ] so that it is worthwhile to look for a 
single metabolic defect underlying the condition. The 
present communication reports altered allosteric on- 
trol of the important regulatory enzyme, phosphofruc- 
tokinase, and suggests that such a change coiJld, in 
principle, account for the obese condition of these 
mice. 
2. Materials and methods 
Mice of strain C57BL/6J-ob (obese) and normal 
controls were obtained from the Jackson Laboratory, 
Bar Harbor, Maine. Mice were killed by decapi- 
tation and a liver extract was obtained by homogeni- 
zing with a Teflon-glass homogenizer in a medium 
containing 20 mM Tris-HCl, pH 8.0, 5 mM MgSO,, 
and 0.1 mM EDTA. Phosphofructokinase was partially 
purified by ammonium sulfate fractionation as des- 
cribed by Underwood and Newsholme [9]. 
Activity was measured essentially as described by 
Paetkau and Lardy [10] with the assay medium con- 
taining 33 mM imidazole, pH 7.0, 1 mM ATP, 4 mM 
MgSO4, 2 mM fructose-6-phosphate, 50 mM KC1, 
1 mM dithiothreitol, 160 pM NADH, 0.1 mI of a 
solution containing saturating amounts of aldolase, 
,~-glycerolphosphate dehydrogenase, and triosephos- 
phate isomerase, the enzymes having been dialyzed 
previously. The reaction mixture included either 0.1 
ml of the crude homogenate or from 40-60 #1 of the 
purified enzyme so that the optical density change 
was about 0.1/min. The reaction was followed in a 
total volume of 1.5 ml at 25°C using a Perkin-Elmer 
Model 356 spectrophotometer set at 340 nm. Protein 
was estimated by the biuret reaction; in the case of 
purified enzyme, protein was precipitated with 10% 
trichloroacetic a id prior to estimation to avoid inter- 
ference from ammonium sulfate. 
3. Results and discussion 
Activity of phosphofructokinase in crude Uver 
homogenates was elevated between two and four 
times in obese mice when compared to normal con- 
trols (table 1). When ammonium sulfate fractionation 
of the extract was carried out, the partially purified 
enzyme from the obese animals exhibited the same 
elevation in specific activity, comparable degrees of 
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Table 1 
Phosphofructokinase ctivity in normal and obese mouse 
liver. Reaction conditions are as described inthe 
methods ection 
Specific a~tivity 
\ .  
(#moles/mm/mg) 
Crude extract Purified enzyme 
Normal 
Obese 
a 0.0012 0.046 
b 0.0028 0.076 
a 0.0046 0.196 
b 0.0046 0.136 
purification having been obtained in each case (about 
40-fold). 
Since allosteric inhibition of phosphofructokinase 
by ATP and citrate represents an important mode of 
regulation of the glycolytic pathway [11 ] it is of 
interest o examine the influence of these compounds 
upon activity of the purified enzyme. Fig. 1 shows 
the characteristic a tivity curve for phosphofructo- 
kinase with changing concentration of ATP, where 
the left hand (ascending) portion reflects the role 
of ATP as a substrate while the right hand portion 
reflects its ability to serve as aUosteric inhibitor. It is 
clear that ATP is a much less effective inhibitor of 
activity in the case of enzyme obtained from obese 
mice. A similar situation occurs with regard to citrate 
inhibition, where comparable concentrations produce 
less inhibition in the case of the obese animals (table 
2). Thus, a second element of the regulation of the 
flow of carbon into the tricarboxylic acid cycle ap- 
pears to operate -with diminished sensitivity. 
A decline in the sensitivity with which phospho- 
fructokinase is modulated by citrate and ATP would 
be expected to lead to increased synthesis of acetyl 
CoA and citrate. Since liver mitochondria from obese 
mice exhibit greater than normal oxidative capability 
as well as enhanced rates of oxidative phosphoryla- 
tion (ref. [4] and unpublished experiments from this 
laboratory), there should be increased availability of 
ATP. High intraceUular concentrations of both ATP 
and citrate would be likely to favor net lipid synthe- 
sis by way of the inducible enzyme, citrate lyase, 
[12] for which both compounds are substrates. In this 
connection it is worth observing that the next enzyme 
in the route from citrate to fatty acids in acetyl CoA 
carboxylase which has also been shown to be elevated 










Fig. 1. The influence of ATP concentration on activity of 
partially purified liver phosphofructokinase. Reaction condi- 
tions were described in the methods section. N denotes en- 
zyme isolated from normal mice; OB, enzyme from obese 
animals. Activity is expressed as percent of that obtained 
with optimal ATP which was 69 ranoles/min/mg in the case 
of normal mice and 190 ranoles/min/mg in that of obese. 
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Table 2 
Inhibition of phosphofructokinase by citrate 
Citrate (mM) % Total activity 
Normal Obese 
0 100 100 
1 100 100 
2 65 88 
5 20 69 
10 2 18 
Reaction conditions were as described in the methods sec- 
tion with citrate concentration asshown. In this experiment, 
total activity was 0.054 and 0.170 ~moles/min/mg fornormal 
and obese animals, respectively. 
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